跳至主要内容
临床试验/IRCT20180422039379N1
IRCT20180422039379N1已完成2 期

Comparison between the effect of oral and intravenous vitamin D3 on statin-induced myopathy level :Randomized Controlled Trial

Ahvaz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • 1. There are symptoms of myalgia with statins
  • 2. Age of patients aged 18 to 65 years.
  • 3. Lower levels of vitamin D (25OH Vitamin D3) from normal range (<32ng / ml).

排除标准

  • 1. Patient does not provide consent.
  • 2. Failure to complete the study
  • 3. Age under 18 and over 65 years.
  • 4. Alcohol or substance abuse.
  • 5. Collagen disease, vascular, coagulopathy, genetic, cerebrovascular disease.
  • 6. Creatine kinase level above 300U / L, indicating fibromyalgia.
  • 7. The patient is not able to use Pearl vitamin D3 or a tendency to inject a drug.
  • 8. The history and evidence of examination indicate trauma in the organs.

研究者

相似试验

Evaluation of oral and injection vitamin D3 on... | 临床试验